Invest now

Suven Life Sciences Profit & Loss Annual

BSE: 530239 | NSE: SUVEN | ISIN: INE495B01038 | Sector: Biotechnology & Drugs
265.90 -2.85 (-1.06%)Updated : 18 Nov 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 296.36178.02138.67139.51
Other Net -0.490.321.480.11
Diluted Weighted Average Shares 22.7821.8121.8117.83
Depreciation/ Amortization 5.615.826.506.54
Operating Income -289.24-171.37-126.98-125.97
Net Income -276.34-160.75-105.08-118.27
Income Availableto Com Excl Extra Ord -276.34-160.75-105.08-118.27
Net Income Before Taxes -276.34-160.75-106.08-118.27
Net Income After Taxes -276.34-160.75-105.08-118.27
Income Availableto Com Incl Extra Ord -276.34-160.75-105.08-118.27
Costof Revenue Total 1.551.340.980.37
Gross Profit 5.575.3210.7213.17
Interest Inc( Exp) Net- Non- Op Total 13.3810.3019.427.59
Diluted Net Income -276.34-160.75-105.08-118.27
Provisionfor Income Taxes 0.000.00-1.000.00
period Type ----
Net Income Before Extra Items -276.34-160.75-105.08-118.27
Total Revenue 7.116.6611.6913.54
period Length 12.0012.0012.0012.00
Revenue 7.116.6611.6913.54
Selling/ General/ Admin Expenses Total 41.0126.9124.2223.25
Diluted Normalized EPS -12.13-7.37-5.04-6.97
Research Development 248.19143.96114.43115.35
Diluted EPS Excluding Extra Ord Items -12.13-7.37-4.82-6.63
Unusual Expense( Income) -0.00-7.46-6.00
Gain( Loss)on Saleof Assets --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,134.10+25.10(2.26%)
297.00+4.00(1.37%)
12,411.00+150.00(1.22%)
4,660.00-236.10 (-4.82%)